More than 1 in 4 of the top TikTok videos about gout were presented by patients with gout or close family members.

Global study reveals alarming rise in gout cases among young people aged 15 to 39, with rates increasing 66% from 1990 to ...

Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...

The burden of cardiovascular-kidney-metabolic (CKM) comorbidities among adults with gout is high, noted Chio Yokose, MD, MSc, ...

Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other ...

In today’s Pharma Pulse, SOBI strengthens its gout franchise by acquiring Arthrosi Therapeutics for up to $1.5 billion, ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...

SOBI has agreed to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly potent and ...

The deal revolves around a drug Sobi claimed could become the “therapy of choice” for people whose gout symptoms persist ...

For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II ...

Fresh off a $153 million series E round, Arthrosi Therapeutics is skipping an IPO route and is instead being bought up for a ...